nodes	percent_of_prediction	percent_of_DWPC	metapath
Lansoprazole—ABCG2—Glyburide—gestational diabetes	0.355	0.418	CbGbCtD
Lansoprazole—CYP2C19—Glyburide—gestational diabetes	0.159	0.187	CbGbCtD
Lansoprazole—CYP2C9—Glyburide—gestational diabetes	0.132	0.155	CbGbCtD
Lansoprazole—ABCB1—Glyburide—gestational diabetes	0.128	0.151	CbGbCtD
Lansoprazole—CYP3A4—Glyburide—gestational diabetes	0.0768	0.0902	CbGbCtD
Lansoprazole—Allergic cutaneous angiitis—Glyburide—gestational diabetes	0.0119	0.0957	CcSEcCtD
Lansoprazole—Leukocytoclastic vasculitis—Glyburide—gestational diabetes	0.00771	0.062	CcSEcCtD
Lansoprazole—Hyperbilirubinaemia—Glyburide—gestational diabetes	0.00416	0.0335	CcSEcCtD
Lansoprazole—Aplastic anaemia—Glyburide—gestational diabetes	0.00355	0.0286	CcSEcCtD
Lansoprazole—Vascular purpura—Glyburide—gestational diabetes	0.00307	0.0247	CcSEcCtD
Lansoprazole—Deafness—Glyburide—gestational diabetes	0.00307	0.0247	CcSEcCtD
Lansoprazole—Haemolytic anaemia—Glyburide—gestational diabetes	0.00304	0.0245	CcSEcCtD
Lansoprazole—Renal failure acute—Glyburide—gestational diabetes	0.00297	0.0239	CcSEcCtD
Lansoprazole—Renal impairment—Glyburide—gestational diabetes	0.00289	0.0232	CcSEcCtD
Lansoprazole—Purpura—Glyburide—gestational diabetes	0.00285	0.0229	CcSEcCtD
Lansoprazole—Arthritis—Glyburide—gestational diabetes	0.00283	0.0227	CcSEcCtD
Lansoprazole—Hypoglycaemia—Glyburide—gestational diabetes	0.00281	0.0226	CcSEcCtD
Lansoprazole—Hyponatraemia—Glyburide—gestational diabetes	0.00276	0.0222	CcSEcCtD
Lansoprazole—Diplopia—Glyburide—gestational diabetes	0.00275	0.0221	CcSEcCtD
Lansoprazole—Abdominal distension—Glyburide—gestational diabetes	0.00239	0.0192	CcSEcCtD
Lansoprazole—Eosinophilia—Glyburide—gestational diabetes	0.00235	0.0189	CcSEcCtD
Lansoprazole—Pancreatitis—Glyburide—gestational diabetes	0.00233	0.0187	CcSEcCtD
Lansoprazole—Pancytopenia—Glyburide—gestational diabetes	0.00225	0.0181	CcSEcCtD
Lansoprazole—Photosensitivity reaction—Glyburide—gestational diabetes	0.00217	0.0174	CcSEcCtD
Lansoprazole—Jaundice—Glyburide—gestational diabetes	0.00206	0.0166	CcSEcCtD
Lansoprazole—Agranulocytosis—Glyburide—gestational diabetes	0.00197	0.0159	CcSEcCtD
Lansoprazole—Hepatitis—Glyburide—gestational diabetes	0.0019	0.0153	CcSEcCtD
Lansoprazole—Visual impairment—Glyburide—gestational diabetes	0.00183	0.0147	CcSEcCtD
Lansoprazole—Eye disorder—Glyburide—gestational diabetes	0.00178	0.0143	CcSEcCtD
Lansoprazole—Alopecia—Glyburide—gestational diabetes	0.00168	0.0135	CcSEcCtD
Lansoprazole—Malnutrition—Glyburide—gestational diabetes	0.00165	0.0133	CcSEcCtD
Lansoprazole—Erythema—Glyburide—gestational diabetes	0.00165	0.0133	CcSEcCtD
Lansoprazole—Vision blurred—Glyburide—gestational diabetes	0.00156	0.0125	CcSEcCtD
Lansoprazole—Tremor—Glyburide—gestational diabetes	0.00155	0.0125	CcSEcCtD
Lansoprazole—Anaemia—Glyburide—gestational diabetes	0.00153	0.0123	CcSEcCtD
Lansoprazole—Angioedema—Glyburide—gestational diabetes	0.00151	0.0122	CcSEcCtD
Lansoprazole—Leukopenia—Glyburide—gestational diabetes	0.00148	0.0119	CcSEcCtD
Lansoprazole—Convulsion—Glyburide—gestational diabetes	0.00143	0.0115	CcSEcCtD
Lansoprazole—Myalgia—Glyburide—gestational diabetes	0.00141	0.0113	CcSEcCtD
Lansoprazole—Arthralgia—Glyburide—gestational diabetes	0.00141	0.0113	CcSEcCtD
Lansoprazole—Confusional state—Glyburide—gestational diabetes	0.00136	0.0109	CcSEcCtD
Lansoprazole—Oedema—Glyburide—gestational diabetes	0.00135	0.0109	CcSEcCtD
Lansoprazole—Shock—Glyburide—gestational diabetes	0.00133	0.0107	CcSEcCtD
Lansoprazole—Nervous system disorder—Glyburide—gestational diabetes	0.00132	0.0106	CcSEcCtD
Lansoprazole—Thrombocytopenia—Glyburide—gestational diabetes	0.00132	0.0106	CcSEcCtD
Lansoprazole—Hyperhidrosis—Glyburide—gestational diabetes	0.0013	0.0105	CcSEcCtD
Lansoprazole—Anorexia—Glyburide—gestational diabetes	0.00129	0.0103	CcSEcCtD
Lansoprazole—Hypotension—Glyburide—gestational diabetes	0.00126	0.0101	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Glyburide—gestational diabetes	0.00123	0.00989	CcSEcCtD
Lansoprazole—Paraesthesia—Glyburide—gestational diabetes	0.00121	0.00975	CcSEcCtD
Lansoprazole—Dyspnoea—Glyburide—gestational diabetes	0.0012	0.00968	CcSEcCtD
Lansoprazole—Dyspepsia—Glyburide—gestational diabetes	0.00119	0.00955	CcSEcCtD
Lansoprazole—Decreased appetite—Glyburide—gestational diabetes	0.00117	0.00943	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Glyburide—gestational diabetes	0.00117	0.00937	CcSEcCtD
Lansoprazole—Feeling abnormal—Glyburide—gestational diabetes	0.00111	0.00894	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Glyburide—gestational diabetes	0.0011	0.00887	CcSEcCtD
Lansoprazole—Urticaria—Glyburide—gestational diabetes	0.00107	0.00862	CcSEcCtD
Lansoprazole—Abdominal pain—Glyburide—gestational diabetes	0.00107	0.00858	CcSEcCtD
Lansoprazole—Hypersensitivity—Glyburide—gestational diabetes	0.000994	0.008	CcSEcCtD
Lansoprazole—Asthenia—Glyburide—gestational diabetes	0.000968	0.00779	CcSEcCtD
Lansoprazole—Pruritus—Glyburide—gestational diabetes	0.000955	0.00768	CcSEcCtD
Lansoprazole—Diarrhoea—Glyburide—gestational diabetes	0.000923	0.00743	CcSEcCtD
Lansoprazole—Vomiting—Glyburide—gestational diabetes	0.000858	0.0069	CcSEcCtD
Lansoprazole—Rash—Glyburide—gestational diabetes	0.000851	0.00684	CcSEcCtD
Lansoprazole—Dermatitis—Glyburide—gestational diabetes	0.00085	0.00684	CcSEcCtD
Lansoprazole—Headache—Glyburide—gestational diabetes	0.000845	0.0068	CcSEcCtD
Lansoprazole—CYP1B1—Endogenous sterols—CYP19A1—gestational diabetes	0.000839	0.0345	CbGpPWpGaD
Lansoprazole—Nausea—Glyburide—gestational diabetes	0.000802	0.00645	CcSEcCtD
Lansoprazole—CYP4A11—Biological oxidations—GGCT—gestational diabetes	0.000748	0.0308	CbGpPWpGaD
Lansoprazole—CYP2C18—FOXA1 transcription factor network—AR—gestational diabetes	0.000659	0.0271	CbGpPWpGaD
Lansoprazole—CYP2C18—Biological oxidations—GGCT—gestational diabetes	0.000654	0.0269	CbGpPWpGaD
Lansoprazole—CYP2C18—Tryptophan metabolism—CYP19A1—gestational diabetes	0.000653	0.0269	CbGpPWpGaD
Lansoprazole—MAPT—MAPK Signaling Pathway—GCK—gestational diabetes	0.000626	0.0258	CbGpPWpGaD
Lansoprazole—CYP4A11—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000604	0.0249	CbGpPWpGaD
Lansoprazole—CYP4A11—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000596	0.0246	CbGpPWpGaD
Lansoprazole—CYP2C18—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000528	0.0218	CbGpPWpGaD
Lansoprazole—CYP2C18—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000521	0.0215	CbGpPWpGaD
Lansoprazole—CYP4A11—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.00049	0.0202	CbGpPWpGaD
Lansoprazole—CYP1B1—Biological oxidations—GGCT—gestational diabetes	0.000482	0.0198	CbGpPWpGaD
Lansoprazole—CYP1B1—Tryptophan metabolism—CYP19A1—gestational diabetes	0.000482	0.0198	CbGpPWpGaD
Lansoprazole—ABCG2—HIF-1-alpha transcription factor network—GCK—gestational diabetes	0.000449	0.0185	CbGpPWpGaD
Lansoprazole—CYP2C18—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000428	0.0176	CbGpPWpGaD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	0.000402	0.0166	CbGpPWpGaD
Lansoprazole—CYP1B1—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000389	0.016	CbGpPWpGaD
Lansoprazole—CYP1B1—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000384	0.0158	CbGpPWpGaD
Lansoprazole—ATP4B—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000366	0.0151	CbGpPWpGaD
Lansoprazole—ATP4A—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000326	0.0134	CbGpPWpGaD
Lansoprazole—CYP1A2—Phase II conjugation—GGCT—gestational diabetes	0.000323	0.0133	CbGpPWpGaD
Lansoprazole—CYP1B1—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000316	0.013	CbGpPWpGaD
Lansoprazole—CYP1A1—Biological oxidations—GGCT—gestational diabetes	0.000297	0.0122	CbGpPWpGaD
Lansoprazole—CYP1A1—Tryptophan metabolism—CYP19A1—gestational diabetes	0.000297	0.0122	CbGpPWpGaD
Lansoprazole—CYP2C8—Biological oxidations—GGCT—gestational diabetes	0.000272	0.0112	CbGpPWpGaD
Lansoprazole—MAPT—Alzheimers Disease—TNF—gestational diabetes	0.000271	0.0112	CbGpPWpGaD
Lansoprazole—CYP4A11—Biological oxidations—CYP19A1—gestational diabetes	0.00026	0.0107	CbGpPWpGaD
Lansoprazole—CYP2C19—Biological oxidations—GGCT—gestational diabetes	0.000243	0.01	CbGpPWpGaD
Lansoprazole—ABCB1—HIF-1-alpha transcription factor network—GCK—gestational diabetes	0.000243	0.01	CbGpPWpGaD
Lansoprazole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.00024	0.00988	CbGpPWpGaD
Lansoprazole—CYP1A1—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000237	0.00975	CbGpPWpGaD
Lansoprazole—ABCG2—HIF-1-alpha transcription factor network—LEP—gestational diabetes	0.00023	0.00946	CbGpPWpGaD
Lansoprazole—CYP2C18—Biological oxidations—CYP19A1—gestational diabetes	0.000227	0.00937	CbGpPWpGaD
Lansoprazole—CYP2C18—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000224	0.00924	CbGpPWpGaD
Lansoprazole—CYP2D6—Biological oxidations—GGCT—gestational diabetes	0.000223	0.0092	CbGpPWpGaD
Lansoprazole—CYP2C9—Biological oxidations—GGCT—gestational diabetes	0.000221	0.00912	CbGpPWpGaD
Lansoprazole—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.00022	0.00906	CbGpPWpGaD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.00022	0.00905	CbGpPWpGaD
Lansoprazole—CYP2C8—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000217	0.00894	CbGpPWpGaD
Lansoprazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000196	0.00808	CbGpPWpGaD
Lansoprazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000194	0.00801	CbGpPWpGaD
Lansoprazole—CYP2C19—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000194	0.00798	CbGpPWpGaD
Lansoprazole—CYP1A2—Biological oxidations—GGCT—gestational diabetes	0.000189	0.00779	CbGpPWpGaD
Lansoprazole—CYP1A2—Tryptophan metabolism—CYP19A1—gestational diabetes	0.000189	0.00779	CbGpPWpGaD
Lansoprazole—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.00018	0.00743	CbGpPWpGaD
Lansoprazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000179	0.00737	CbGpPWpGaD
Lansoprazole—CYP2C8—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000178	0.00734	CbGpPWpGaD
Lansoprazole—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000178	0.00734	CbGpPWpGaD
Lansoprazole—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000177	0.00727	CbGpPWpGaD
Lansoprazole—CYP1B1—Biological oxidations—CYP19A1—gestational diabetes	0.000168	0.00691	CbGpPWpGaD
Lansoprazole—CYP1B1—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000165	0.00681	CbGpPWpGaD
Lansoprazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000159	0.00655	CbGpPWpGaD
Lansoprazole—MAPT—Apoptosis—TNF—gestational diabetes	0.000158	0.00651	CbGpPWpGaD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—gestational diabetes	0.000156	0.00642	CbGpPWpGaD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	0.000156	0.00642	CbGpPWpGaD
Lansoprazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000153	0.0063	CbGpPWpGaD
Lansoprazole—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000151	0.00622	CbGpPWpGaD
Lansoprazole—MAPT—MAPK Signaling Pathway—TNF—gestational diabetes	0.000148	0.00611	CbGpPWpGaD
Lansoprazole—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000146	0.00603	CbGpPWpGaD
Lansoprazole—CYP3A4—Biological oxidations—GGCT—gestational diabetes	0.000146	0.00602	CbGpPWpGaD
Lansoprazole—CYP3A4—Tryptophan metabolism—CYP19A1—gestational diabetes	0.000146	0.00601	CbGpPWpGaD
Lansoprazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000145	0.00597	CbGpPWpGaD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.000134	0.00551	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—GGCT—gestational diabetes	0.000128	0.00527	CbGpPWpGaD
Lansoprazole—ABCB1—HIF-1-alpha transcription factor network—LEP—gestational diabetes	0.000124	0.00511	CbGpPWpGaD
Lansoprazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000124	0.00511	CbGpPWpGaD
Lansoprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000118	0.00486	CbGpPWpGaD
Lansoprazole—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000116	0.0048	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—GLS2—gestational diabetes	0.000112	0.0046	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—GGCT—gestational diabetes	0.000112	0.0046	CbGpPWpGaD
Lansoprazole—CYP1A1—Biological oxidations—CYP19A1—gestational diabetes	0.000103	0.00425	CbGpPWpGaD
Lansoprazole—CYP1A1—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000102	0.0042	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	9.99e-05	0.00412	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—GLS2—gestational diabetes	9.77e-05	0.00402	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—gestational diabetes	9.6e-05	0.00395	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	9.6e-05	0.00395	CbGpPWpGaD
Lansoprazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	9.57e-05	0.00394	CbGpPWpGaD
Lansoprazole—CYP2C8—Biological oxidations—CYP19A1—gestational diabetes	9.47e-05	0.0039	CbGpPWpGaD
Lansoprazole—CYP2C8—Metapathway biotransformation—CYP19A1—gestational diabetes	9.34e-05	0.00385	CbGpPWpGaD
Lansoprazole—CYP2C19—Biological oxidations—CYP19A1—gestational diabetes	8.45e-05	0.00348	CbGpPWpGaD
Lansoprazole—CYP2C19—Metapathway biotransformation—CYP19A1—gestational diabetes	8.33e-05	0.00343	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—GGCT—gestational diabetes	8.24e-05	0.00339	CbGpPWpGaD
Lansoprazole—CYP2D6—Biological oxidations—CYP19A1—gestational diabetes	7.77e-05	0.0032	CbGpPWpGaD
Lansoprazole—CYP2C9—Biological oxidations—CYP19A1—gestational diabetes	7.71e-05	0.00317	CbGpPWpGaD
Lansoprazole—CYP2D6—Metapathway biotransformation—CYP19A1—gestational diabetes	7.67e-05	0.00316	CbGpPWpGaD
Lansoprazole—ABCG2—Transmembrane transport of small molecules—GCK—gestational diabetes	7.62e-05	0.00314	CbGpPWpGaD
Lansoprazole—CYP2C9—Metapathway biotransformation—CYP19A1—gestational diabetes	7.6e-05	0.00313	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—GGCT—gestational diabetes	7.5e-05	0.00309	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	7.38e-05	0.00304	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—GLS2—gestational diabetes	7.2e-05	0.00297	CbGpPWpGaD
Lansoprazole—CYP1A2—Biological oxidations—CYP19A1—gestational diabetes	6.58e-05	0.00271	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—GLS2—gestational diabetes	6.55e-05	0.0027	CbGpPWpGaD
Lansoprazole—CYP1A2—Metapathway biotransformation—CYP19A1—gestational diabetes	6.49e-05	0.00267	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	6.44e-05	0.00265	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—NAMPT—gestational diabetes	6.12e-05	0.00252	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	6.12e-05	0.00252	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—gestational diabetes	6.12e-05	0.00252	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—GCK—gestational diabetes	6.09e-05	0.00251	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—NAMPT—gestational diabetes	5.35e-05	0.00221	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—GCK—gestational diabetes	5.32e-05	0.00219	CbGpPWpGaD
Lansoprazole—CYP3A4—Biological oxidations—CYP19A1—gestational diabetes	5.08e-05	0.00209	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—GGCT—gestational diabetes	5.08e-05	0.00209	CbGpPWpGaD
Lansoprazole—CYP3A4—Metapathway biotransformation—CYP19A1—gestational diabetes	5.01e-05	0.00206	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—TNF—gestational diabetes	4.97e-05	0.00205	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GGCT—gestational diabetes	4.65e-05	0.00192	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—CYP19A1—gestational diabetes	4.45e-05	0.00183	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—GLS2—gestational diabetes	4.44e-05	0.00183	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GGCT—gestational diabetes	4.15e-05	0.00171	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—GCK—gestational diabetes	4.12e-05	0.0017	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GLS2—gestational diabetes	4.07e-05	0.00168	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GGCT—gestational diabetes	4.05e-05	0.00167	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	4.03e-05	0.00166	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	3.97e-05	0.00163	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—NAMPT—gestational diabetes	3.95e-05	0.00163	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—GCK—gestational diabetes	3.92e-05	0.00162	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—CYP19A1—gestational diabetes	3.89e-05	0.0016	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GGCT—gestational diabetes	3.82e-05	0.00157	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GGCT—gestational diabetes	3.79e-05	0.00156	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	3.64e-05	0.0015	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GLS2—gestational diabetes	3.63e-05	0.0015	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—NAMPT—gestational diabetes	3.59e-05	0.00148	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—GCK—gestational diabetes	3.57e-05	0.00147	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GLS2—gestational diabetes	3.54e-05	0.00146	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GLS2—gestational diabetes	3.34e-05	0.00138	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GLS2—gestational diabetes	3.31e-05	0.00136	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	3.25e-05	0.00134	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GGCT—gestational diabetes	3.24e-05	0.00133	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	2.96e-05	0.00122	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—CYP19A1—gestational diabetes	2.87e-05	0.00118	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GLS2—gestational diabetes	2.83e-05	0.00117	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—CYP19A1—gestational diabetes	2.61e-05	0.00107	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	2.53e-05	0.00104	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GGCT—gestational diabetes	2.5e-05	0.00103	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	2.45e-05	0.00101	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—NAMPT—gestational diabetes	2.43e-05	0.001	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—GCK—gestational diabetes	2.42e-05	0.000995	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—NAMPT—gestational diabetes	2.23e-05	0.000918	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GCK—gestational diabetes	2.21e-05	0.000912	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GLS2—gestational diabetes	2.18e-05	0.000899	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—NAMPT—gestational diabetes	1.99e-05	0.000819	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GCK—gestational diabetes	1.98e-05	0.000814	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—NAMPT—gestational diabetes	1.94e-05	0.0008	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GCK—gestational diabetes	1.93e-05	0.000795	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—NAMPT—gestational diabetes	1.83e-05	0.000754	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GCK—gestational diabetes	1.82e-05	0.000749	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—NAMPT—gestational diabetes	1.81e-05	0.000747	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GCK—gestational diabetes	1.8e-05	0.000742	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CYP19A1—gestational diabetes	1.77e-05	0.000727	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CYP19A1—gestational diabetes	1.62e-05	0.000667	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—NAMPT—gestational diabetes	1.55e-05	0.000638	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GCK—gestational diabetes	1.54e-05	0.000634	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CYP19A1—gestational diabetes	1.45e-05	0.000595	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CYP19A1—gestational diabetes	1.41e-05	0.000581	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CYP19A1—gestational diabetes	1.33e-05	0.000547	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CYP19A1—gestational diabetes	1.32e-05	0.000543	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—NAMPT—gestational diabetes	1.2e-05	0.000493	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GCK—gestational diabetes	1.19e-05	0.00049	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CYP19A1—gestational diabetes	1.13e-05	0.000464	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CYP19A1—gestational diabetes	8.69e-06	0.000358	CbGpPWpGaD
